Similar Articles |
|
Managed Care August 2004 |
Headlines On Deadline ... Expanded Medicare coverage for obesity is the result of the government's removal of language from the Medicare manual that states that the condition is not an illness... Earnings soared 36 percent for UnitedHealth Group in the second quarter... etc. |
Managed Care February 2005 |
Medicare's Drug Coverage Seeks To Strike Compromise Health plan officials are still trying to determine just how the final rules for the new Medicare prescription drug benefit will affect them, because it appears that government officials tried their best to address the competing concerns of all players. |
Managed Care May 2002 |
Drug Companies Unveil Their Plan For Discount Card In the absence of any congressional action on a pharmacy benefit in Medicare, seven pharmaceutical companies have teamed up to offer a drug discount card that many call a vital first step in shoring up Medicare coverage |
The Motley Fool February 23, 2004 Brian Gorman |
Hershey Gets in the Zone The chocolate king partners with the Zone diet for a new low-carb bar. |
The Motley Fool October 12, 2004 Brian Gorman |
Abbott's Healthy Diet Is the company's push into nutritional supplements a wise move? |
The Motley Fool January 22, 2007 Dan Caplinger |
Understanding Medicare: Claims In general, Medicare provides a level of coverage that is fairly similar to what private health insurance plans offer. Here are some tips for getting the most from it. |
The Motley Fool January 22, 2007 Dan Caplinger |
Understanding Medicare: Benefits Medical coverage for seniors is a big part of a strong retirement-protection plan. |
The Motley Fool June 17, 2004 Seth Jayson |
Big Business vs. Big Pharma An organization of human resources executives from companies that employ 12% of the private sector U.S. workforce is working to create a prescription drug "buyer's club," with the help of HR management firm Hewitt Associates. |
Managed Care November 2007 |
Patient Advocates Want Part D Changes A Medicare-administered drug benefit would be more affordable and comprehensive than the current private insurance-run drug benefit, say patient advocate groups. |
Managed Care February 2006 |
For Drugs, the VA Pays Far Less Than Medicare A recent survey indicates that prices for the top 20 drugs used by Medicare enrollees are much higher than prices negotiated by the Department of Veterans Affairs. |
The Motley Fool April 5, 2005 Stephen D. Simpson |
Can Obesity Fatten Your Wallet? Obesity is an increasingly serious problem, but could it also be a major opportunity for health-care companies? Investors should spend a little due diligence on the pharmaceutical side. |
Chemistry World July 18, 2012 Andrew Turley |
Obesity drug approved in US US regulators have approved a new obesity treatment. Qsymia (phentermine, topiramate) tablets have been approved for overweight adults as part of a regimen that includes a low calorie diet and exercise. |
Managed Care April 2005 |
Medicare Modernization Act to Increase Public Sector Spending Nearly 50 Percent While the burden on the public sector to supply health care benefits to Medicare and Medicaid enrollees will increase, on the private side, a reevaluation of current forms of health insurance coverage may take place as growth in premiums continues to outpace growth in compensation. |
Managed Care January 2007 |
Seventy-Five Percent of Cancer Drugs Covered Under Medicare Part D Seventy-five percent of cancer drugs are covered by Medicare Part D plans, with regional Medicare Advantage prescription drug plans covering 85 percent. |
BusinessWeek October 3, 2005 Howard Gleckman |
Medicare: Decisions, Decisions With drug and HMO plans now in the mix, seniors face a raft of complex choices. |
Managed Care August 2000 |
Medicare+Choice pullouts' deep, deep sting The health plan exodus from Medicare+Choice will affect 934,000 people in 2001 -- more than were affected in 1999 and 2000 combined, according to the Health Care Financing Administration. |
Pharmaceutical Executive January 1, 2006 Bill Shearer |
Patient Assistant Programs and Medicare Part D About 2.5 million low-income seniors who participate in prescription access programs are eligible for drug coverage under Medicare Part D - but the programs are out of alignment. |
Managed Care January 2006 Martin Sipkoff |
Skeptics Abound as Demand Grows For Obesity Treatments Changes in reimbursement patterns for obesity drugs will take several years. Lifestyle changes remain the first approach. |
American Family Physician June 1, 2006 Last & Wilson |
Low-Carbohydrate Diets Because of their higher protein and fat content and lower fiber and carbohydrate content, concerns have been raised about the potential health consequences of low-carbohydrate diets. Published long-term data are lacking. Here are key recommendations for physicians. |
Knowledge@Wharton |
Prescription Drug Coverage for Seniors Faces Uncertain Future The discussion about adding a prescription drug benefit to Medicare will be put on hold... |
Pharmaceutical Executive October 1, 2008 Jill Wechsler |
Part D Under Attack Congressional leaders ready campaign to curb Medicare drug plans. |
Financial Planning February 1, 2006 Janet Aschkenasy |
Drug Deals Here is how to help your financial advisory clients make sense of Medicare Part D. |
Managed Care November 2001 |
Medicare+Choice Problems Chasing Away 58 Health Plans Medicare+Choice, the program that was supposed to ease the elderly into managed care, is itself suffering from the uneasiness of HMOs dissatisfied with payment rates... |
Managed Care May 2000 |
Prescription Drug Benefit Gaining In Election Year Considered a dead issue just weeks ago, a prescription drug benefit in Medicare is suddenly thought to be the health care issue with the best chance for passage this year.... |
AskMen.com July 7, 2014 Patrick Owen |
Is It Impossible To Keep The Weight Off? The world is fatter than ever. In 2010 there were 1.5 billion people worldwide who were obese, and the trend is growing. |
The Motley Fool August 13, 2004 Phil Wohl |
Weight Watchers Losing Points Their litigation battle with CoolBrands, combined with softer attendance levels, gives one investment pause. |
The Motley Fool April 22, 2009 Selena Maranjian |
Will Health-Care Reform Hurt Investors? The bad news here is that there's quite a bit of uncertainty around this issue, and that some health-care-focused companies may end up suffering. Read on to see who. |
Managed Care March 2007 |
Use of Generics On the Rise Recent data indicate that generic medication accounts for nearly 60% of the drugs dispensed to people in Medicare Prescription Drug Plans and Medicare Advantage plans. |
Pharmaceutical Executive December 1, 2008 Jill Wechsler |
Challenge and Challenges Expanded healthcare coverage also fits the goals of pharma manufacturers. |
The Motley Fool January 26, 2007 Dan Caplinger |
Fall Into the Medigap Unfortunately, choosing the best Medigap policy for your particular situation can be complicated. You have to analyze the various options included in the plans that are available to you. |
BusinessWeek July 25, 2005 Arlene Weintraub |
Miracle Cure -- Or Weak Medicine Why investors' hopes for a prescription drug bonanza may be premature. |
Pharmaceutical Executive June 1, 2005 Jill Wechsler |
Washington Report: "D" Is for Data It is critical for Medicare to address important questions on drug safety and utilization, and about how prescribing decisions affect health outcomes and costs. |
The Motley Fool June 9, 2004 Phil Wohl |
Smithfield Going Hog Wild Will the world's largest pork processor continue to bring home the bacon? |
Managed Care December 2002 |
M+C meltdown hinders access to medications The fact that health plans are abandoning Medicare+Choice at a slower rate than in previous years doesn't mask the fact that the exodus of plans only exacerbates the problem of lack of pharmaceutical coverage for the elderly. |
Registered Rep. October 13, 2011 Mark Miller |
Determining Your Elderly Clients' Best-Fit in Medicare Plans You may be able to help senior clients save thousands of dollars in out-of-pocket health care costs by encouraging them to comparison shop for Medicare prescription drug and managed care options during the program's annual fall enrollment season. |
AskMen.com Phil Franklin |
Is A Low-Carb Diet Right For You? While there are those who suggest that the low-carb craze has finally reached its zenith, millions of people the world over continue to use these diets to regulate their weight. |
The Motley Fool May 19, 2011 Jeff Bailey |
Weight-Loss: Industry of the Future, But Two Stocks Not Currently Fit for Consumption Which of these weight-losers will help your portfolio gain? |
The Motley Fool March 22, 2004 Seth Jayson |
Stent Wars Going Strong New studies show stents do little to stop heart attacks. What does that mean for stent makers? |
Financial Advisor March 2006 Karen DeMasters |
Clients Lost In Medicare Lurch Although some of the more than 40 million eligible Medicare recipients in the nation already have signed up for the new prescription drug benefits program Part D, many people still are seeking the advice of financial planners and weighing the options that are available to them. |
The Motley Fool June 15, 2004 Brian Gorman |
Abbott's Gambit Abbott Laboratories is making a high-stakes stand on drug pricing in a dispute that threatens to make hostages out of the pharmaceutical industry and its investors. |
The Motley Fool November 22, 2005 Brian Gorman |
Saying No to Drugs Britain's policy of restricting drug access based on cost-benefit analyses should be on the radar screen of pharmaceutical investors. |
Registered Rep. January 2, 2013 Kevin McKinley |
Mapping the Medicare Maze Advisors can shed some much-appreciated light on this crucial but confusing program. |
Pharmaceutical Executive October 1, 2005 Philip A. George |
Backpage: Under Surveillance Doctors and consumers don't doubt that pharma benefits society. But in the eyes of the public, industry efforts to monitor postmarket safety come up short. |
Managed Care April 2005 Frank Diamond |
Starting Medicare Advantage Plan Brings Special Set of Problems The feds will help you launch a health plan for the elderly, but just what does it take to get something like this operating in so short a time? |
AskMen.com March 8, 2014 |
What You Should Eat To Get The Best Real-World Results AskMen staffers try out four faddish diet plans -- paleolithic, vegan, gluten-free and alternate-day fasting -- to see how they measure up. |
The Motley Fool January 22, 2007 Michael P. Cecil |
Will Medicare Negotiate With Drug Companies? One of the bedrock principles of our economic system is that those buying more of a product receive a discount. Wouldn't empowering Medicare to save taxpayers' money be widely embraced as a great idea? But how would pharma investors see it? |
Pharmaceutical Executive October 1, 2011 Jill Wechsler |
An 'A' for Advancing Expectations As head of both the Food and Drug Administration and the Centers for Medicare and Medicaid Services, Mark McClellan has been at the center of public policy affecting the pharmaceutical industry over the last decade. |
The Motley Fool October 3, 2006 Brian Gorman |
Britain's Psychiatric Stir-Up The U.S. government may be forced to follow Great Britain's example regarding drug reimbursements, given recent developments in Medicare. What will this mean for Big Pharma? |
The Motley Fool December 6, 2004 Brian Gorman |
Pill-Popping Nation Americans are using more prescription drugs. Unfortunately for big pharma investors, pharmaceutical companies' benefits from these trends are tempered by other factors. |
Managed Care July 2000 Michael Levin-Epstein |
Congress Asked To Take Action As HMOs Flee Managed Medicare Thanks mainly to the increasing cost of providing a prescription drug benefit, HMOs are exiting Medicare+Choice, the system that was supposed to manage the health of the nation's senior citizens, in droves. Only an act of Congress can save Medicare+Choice, but is seems doubtful that will happen. |